The majority of new chemical entities emerging from today’s discovery pipelines are too poorly water-soluble to allow for reproducible absorption after oral administration. Poor oral absorption dramatically complicates drug development and prevents patients from accessing potentially life-saving therapeutics.
SeraNovo’s technology tackles this solubility problem.
This website uses cookies to track the usage of it.
More info
